The store will not work correctly when cookies are disabled.
methyl 7-decyl-2-methoxy-2-oxo-4,5-dihydro-1,3,2lambda5-dioxaphosphepine-6-carboxylate
ID: ALA5197080
PubChem CID: 168289281
Max Phase: Preclinical
Molecular Formula: C17H31O6P
Molecular Weight: 362.40
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCCCCCC1=C(C(=O)OC)CCOP(=O)(OC)O1
Standard InChI: InChI=1S/C17H31O6P/c1-4-5-6-7-8-9-10-11-12-16-15(17(18)20-2)13-14-22-24(19,21-3)23-16/h4-14H2,1-3H3
Standard InChI Key: HDDYJEDJKYCBQL-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 24 0 0 0 0 0 0 0 0999 V2000
-3.5625 -0.5221 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
-2.9143 -0.0117 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1099 -0.1955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7510 -0.9363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1093 -1.6861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9143 -1.8700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5625 -1.3548 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9251 -0.9363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5122 -0.2208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5122 -1.6515 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3134 -1.6515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5256 0.3885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9763 0.1944 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.3884 -0.5221 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.8014 -1.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7276 0.1746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1434 0.7588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6546 0.5450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2387 1.1293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0368 0.9154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6211 1.4995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4191 1.2858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0033 1.8700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8014 1.6561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
1 7 1 0
7 6 1 0
4 8 1 0
8 9 2 0
8 10 1 0
10 11 1 0
3 12 1 0
1 13 2 0
1 14 1 0
14 15 1 0
12 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 362.40 | Molecular Weight (Monoisotopic): 362.1858 | AlogP: 5.14 | #Rotatable Bonds: 11 |
Polar Surface Area: 71.06 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.50 | CX LogD: 4.50 |
Aromatic Rings: ┄ | Heavy Atoms: 24 | QED Weighted: 0.29 | Np Likeness Score: 0.40 |
References
1. Cavalier JF, Spilling CD, Durand T, Camoin L, Canaan S.. (2021) Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery., 209 [PMID:33071055] [10.1016/j.ejmech.2020.112908] |